- Report
- August 2025
- 150 Pages
Global
From €5273EUR$5,950USD£4,524GBP
- Report
- June 2026
- 145 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- May 2026
- 140 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- April 2026
- 138 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- April 2026
- 137 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- April 2026
- 139 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- April 2026
- 141 Pages
Global
From €2658EUR$2,999USD£2,280GBP
€3544EUR$3,999USD£3,041GBP
- Report
- May 2026
- 188 Pages
Global
From €3988EUR$4,500USD£3,422GBP
- Report
- August 2026
- 278 Pages
Global
From €5184EUR$5,850USD£4,448GBP
- Report
- January 2026
- 195 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- January 2026
- 199 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- January 2026
- 186 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- January 2026
- 196 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 197 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 199 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 194 Pages
Global
From €3142EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 180 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 194 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 184 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP
- Report
- August 2026
- 188 Pages
Global
From €3141EUR$3,545USD£2,696GBP
€3491EUR$3,939USD£2,995GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more